Vendevia Group

Biomedical Venture Development

Portfolio Companies

bioRASI,  www.biorasi.com, Full-service, global CRO conducting preclinical and clinical development of small molecule drugs, biologicals and medical devices.

Medistem (MEDS.OB). Early clinical development stage public company. It's mission is to discover, develop and commercialize technologies related to adult stem cell extraction and manipulation for use in treating inflammatory and degenerative diseases.

OncoMune,  www.oncomune.com, Late preclinical stage cancer vaccine company focused on a newly-discovered, epigenetic transcription factor called Brother of the Regulator of Imprinted Sites (BORIS).

Academy Clinical Research, www.academyclinical.com.  A boutique clinical research site located in the heart of Los Angeles, California.   As a multi-therapeutic practice, it specializes in Phase I through Phase IV clinical trials. 

Academy BioPharma, www.academybiopharma.com. Preclinical small molecule drugs company that develops  innovative and 505(b)(2) drugs and delivery formulations.

 

 

 

 

 

Text Box: Vendevia Development Milestones